Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 334T3 | IM / LA |
Patient received 2 doses of Shingrix back in 2021/2022 (before age 50) and it was not caught until after administration of a 3rd dose on 12/5/24. Patient had no adverse reaction to 3rd dose. Reporting because vaccination is outside of recommended vaccine schedule.
None
None
None
None